Ticker Scorecard - ARVN Basics Company: Arvinas, Inc. IPO Date: September 24, 2018 Sector: Healthcare Industry: Biotech Market Cap: $1.24B Activated in VL: True Average Daily Range Avg Daily Range: $1.15 | 2.93% Avg Daily Range (30 D): $0.49 | 2.64% Avg Daily Range (90 D): $0.65 | 2.84% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .72M Avg Daily Volume (90 D): .62M Trade Size Avg Trade Size (Sh.): 63 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 2,824 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $1.97M Avg Inst. Trade (90 D): $1.71M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.68M Avg Closing Trade (30 D): $1.97M Avg Closing Trade (90 D): $2.06M Avg Closing Volume: 63.87K     News Jan 21, 2025 @ 9:29 AM 2 Growth Stocks That Could Rocket Higher in the Fi... Source: Cory Renauer Dec 10, 2024 @ 6:23 PM Arvinas-Pfizer Partner Cancer Drug Trial Shows 63%... Source: Vandana Singh Nov 27, 2024 @ 12:00 PM Arvinas to Present at Piper Sandler 36th Annual He... Source: N/A Nov 4, 2024 @ 12:00 PM Arvinas to Participate in Upcoming Investor Confer... Source: N/A Oct 21, 2024 @ 11:00 AM Arvinas to Report Third Quarter 2024 Financial Res... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-4.79 $-.68 $-.49 Diluted EPS $-4.79 $-.68 $-.49 Revenue $ 161.1M $ 102.4M $ 76.5M Gross Profit $ $ $ Net Income / Loss $ -308.6M $ -49.2M $ -35.2M Operating Income / Loss $ -357.4M $ -60.3M $ -48.5M Cost of Revenue $ $ $ Net Cash Flow $ -34M $ -75.1M $ 66.8M PE Ratio